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Introduction
Adhesion between cells and between cells and the sur-
rounding extracellular matrix is essential in the dynamic
process necessary for tissue morphogenesis and differ-
entiation in adult organisms [1]. The specific transmem-
brane proteins that regulate the adhesive interactions
have been identified as cadherins, integrins, selectins, the
immunoglobulin superfamily, phosphatase of protein
thyrosine receptor and hyaluron receptors [2]. 
The cadherin family divides into a few subgroups
based on their tissue distribution: E-cadherin (epithe-
lial), P-cadherin (placenta), N-cadherin (neural) and 
L-CAM (liver) [3-6]. 
Cadherins form complexes with cytoplasmic pro-
teins – catenins which occur in three types: α- and β-
catenins and plactoglobine (γ-catenin) [7].
E-cadherin (E-cad), known as uvomorulin, L-
CAM, cell-cell 120/80 or Arc-1, is present in all
epithelial cells [8]. This protein plays a fundamental
role in the maintenance of cellular differentiation and
normal epithelial tissue architecture [9]. Its intracellu-
lar domain interacts with catenins to form the cyto-
plasmic cell adhesion complex (CCC). E-cadherin
binds β-catenin or γ-catenin, when α-catenin binds 
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Abstract: The E-cadherin-catenin complex plays an important role in the process of cell adhesion. Its dysfunction is associated
with a decrease in cell differentiation and with increased invasiveness and metastasis. Our aim was to evaluate the expression of
E-cadherin and B-catenin in advanced gastric cancer in relation to selected clinico-pathomorphological parameters. Formalin-
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E-Cad, Novocastra Laboratiries Ltd; dilution 1:50), β-catenin (NCL-B-CAT, Novocastra Laboratories Ltd; dilution 1:100), α-
catenin (α-E-caten, Santa Cruz Biotechnology; dilution 1:300) and γ-catenin (γ-catenin, Santa Cruz Biotechnology; dilution
1:100). The expressions of E-cadherin and α-, β-, γ-catenins in the main mass of tumor and lymph node metastasis were inves-
tigated in 91 patients with gastric cancer. No statistically significant correlation was observed between the expressions of E-cad-
herin, α-, β-catenins and histological differentiation and between the expressions of E-cadherin, α-, γ-catenins and location or
depth of invasion. Moreover, the expression of α-, γ-catenins in the main mass of tumor was not associated with lymph node
metastasis. However, we found a relationship between the expression of β-catenin in the main mass of tumor and lymph node
metastasis and tumor location. The depth of invasion was correlated with positive expression of β-catenin in the main mass of
gastric cancer. A statistically significant association was observed between the expressions of E-cadherin and β-catenin in the
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E-cadherin and postoperative survival time. No significant correlation was found between the expression of α-, β-, γ-catenins
and survival time. Our results may suggest that the E-cadherin-catenin complex is the factor indicative of metastasis and disease
progression in gastric cancer. Also the expression of E-cadherin may play a role as a prognostic factor.
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β-catenin and γ-catenin but not E-cadherin. The pres-
ence of two different complexes within the same cell
results in specific binding. One complex consists of E-
cadherin, α- and β-catenin, whereas the other contains
E-cadherins and α- and γ-catenins [10].
Reduction in E-cadherin expression or its loss has
been described in carcinomas affecting many organs,
including the large intestine [11], the stomach [12], the
esophagus [13], the lungs [14], or the prostate [15].
β-catenin plays two important functions. It is
involved in cell adhesion, binding E-cadherin to the
actin cytoskeleton via α-catenin [16]. β-catenin is also
a key element in cell signaling via the WNT/wingless
pathway. It is usually "confiscated" in the process of
adhesion with E-cadherin. Free β-catenin undergoes
proteasomal degradation via phosphorylation by
glycogen synthetase kinase 3β (GSK-3β). When the
activity of GSK-3β is blocked by activation of the
WNT pathway, β-catenin accumulates within the cyto-
plasm at high levels [17]. Mutations in β-catenin gene
are uncommon  in lung, breast or kidney carcinoma
cell lines. However, it has been demonstrated that
deletion in a part of the β-catenin gene in a signet ring
cell carcinoma cell line is responsible for dysfunction-
al E-cadherin expression [18].
The α-catenin is directly bound to the cytoplasmic
domain of the cadherin. This binding is the first step in
a complex connection between cadherin and the actin
filament. Mutation in α-catenin gene can be one of the
mechanisms responsible for the loss of proper cell-cell
adhesion [2].
γ-catenin shows strong expression in normal tis-
sues, but not in tumors. The loss of γ-catenin expres-
sion can be due to the presence of the two cadherin-
catenin complexes within a cell. Moreover, γ-catenin
exhibits high homology with β-catenin, which sug-
gests that these proteins may be functionally inter-
changeable [2]. 
The E-cadherin-catenin complex plays an important
role in the process of cell adhesion and partly in cell sig-
nal transduction. Its dysfunction is associated with a
reduction or loss of cell and tissue differentiation and
with higher invasiveness and metastasis potential. In the
present study, we made an attempt to investigate the role
of the E-cadherin- catenin complex in the process of
metastasizing advanced gastric carcinomas.
Material and methods 
Collection of samples. The study was conducted on a group of 91
patients (29 women, 62 men) with advanced gastric carcinoma
treated surgically in II Department of General Surgery and Gas-
troenterology, Medical University of Bia³ystok in the years 1998-
2003. 
Immunohistochemistry. Formalin-fixed, paraffin-embedded tis-
sue specimens were cut on a microtome into 5 μm thick sections,
which were then deparaffinized in xylenes and hydrated in alcohol
series of a decreasing concentration. In order to visualize antigen,
the sections were heated in a microwave for 15 min in citrate buffer
(pH 6.0) and incubated with 0.5% hydrogen peroxide. To block the
endogenous activity of peroxidase, incubation was performed in
blocking serum (Novostain Super ABC Universal Kit) for 30 min.
Next, the samples were incubated with monoclonal antibodies: 
E-cadherin (NCL-E-Cad, Novocastra Laboratories Ltd; dilution
1:50) – for 60 min, β-catenin (NCL-B-CAT, Novocastra Laborato-
ries Ltd) – for 60 min; dilution 1:100, α-cathenin (α-E-caten, Santa
Cruz Biotechnology) – overnight at 4°C, dilution 1:300 and γ-
catenin (γ-catenin, Santa Cruz Biotechnology) – overnight at 4oC,
dilution 1:100. Reaction was performed in ABC technique using
Novostain Super ABC Universal Kit (NCL-ABCm, Novocastra
Laboratories Ltd.). Color reaction for peroxidase was done with
DAB chromogen (DAKO S3000, DAKO, Poland).
Evaluation of samples. Protein expression was assessed using a
semi-quantitative method and defined as follows:
• High expression – when more than 30% cancer cells were E-
cadherin-catenin positive
• Low expression – when there was no reaction or less than 30%
of cells were E-cadherin-catenin positive.
At least 500 cancer cells in each tissue specimen were micro-
scopically found to be E-cadherin-catenin positive (400×).
Statistical analysis. Statistical analysis was carried out based on
the χ2 test and Fisher's exact test. The value of p<0.05 was consid-
ered statistically significant. The correlation between the expres-
sions of the proteins examined and postoperative survival was
determined by Cox analysis.
Results
Statistical analysis showed no relationship between the
expression of the E-cadherin-catenin complex in the
main mass of tumor and gender. What is more, no rela-
tionship was also observed between E-cadherin, α-, γ-
catenin and tumor location or invasion depth.  Moreover,
there was no correlation found between E-cadherin and
β-, α-catenin expression in tumor and histological dif-
ferentiation grade. Also the expression of α- and γ-
catenin was not correlated with lymph node involvement
(Table 1, 3). However, a statistically significant correla-
tion was revealed of β-catenin expression with tumor
location (p=0.023) and depth of stomach wall penetra-
tion (p=0.027) (Table 1). In advanced gastric cancer the
expressions of E-cadherin and β-catenin were strongly
correlated with metastases to lymph nodes (p<0.05)
(Table 2). Tumor γ-catenin expression was found to cor-
relate with histological differentiation grade (p=0.02)
and with Lauren's classification (p=0.002) (Table 1).
Moreover, there was a borderline association between β-
catenin expression in the affected lymph node and tumor
location (p=0.07) (Table 2). No correlation was revealed
between the expressions of E-cadherin, α- and γ-catenin
in the affected lymph node and the parameters studied
(Table 2,4). Analysis of survival rate in patients with
advanced gastric cancer showed a statistically significant
correlation with E-cadherin expression in the main mass
of tumor (p<0.05; Fig. 1). Patients with E-cadherin-pos-
itive tumors showed a 46-month-survival after surgery as
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Table 1. Correlation between the expression of E-cadherin, β-catenin proteins and clinicopathological parameters in gastric cancer. 
NS – non statistical significence 
NS – non statistical significence 
Table 2. Correlation between the expression of E-cadherin,  β-catenin proteins and clinicopatholgical parameters in lymph node metastasis.
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Table 3. Association between the expression of  α-cadherin, γ-catenin and clinicopathological parameters in main mass of gastric carcinoma.
NS – non statistical significence 
NS – non statistical significence 
Table 4. Association between the expression of  α-cadherin, γ-catenin and clinicopathological parameters in lymph node metastasis.
compared to 62 months observed in those without the
expression. Increased mortality in patients with strong
immunohistochemical reaction in tumor was noted
between 5-32 months after surgery. No correlation was
observed between positive staining for α-, β- and 
γ-catenins in the main mass of tumor and survival rate
(Fig. 2, 3, 4). Patients with tumor α- and β-catenin
expression had much longer survival (89 months) as
compared to those with the expression loss (61 months).
An opposite correlation was recorded in the case of 
γ-catenin expression: patients with positive tumor 
γ-catenin expression were found to survive for about 60
months after surgery as compared to those without (84
months). 
Discussion
E-cadherin mediates adhesive interactions between
epithelial cells and exerts an effect on the organization
of the actin cytoskeleton through binding to catenins.
E-cadherin has been defined as a suppressor gene of
invasion that is frequently inhibited or undergoes
mutation in invasive tumors [19]. Dysfunction of
CDH1 gene (E-cadherin-coding gene) together with
mutation have been found in diffuse-type gastric carci-
noma [20]. Mutation in CDH1 is a genetic defect
found in approximately 1/3 of familial gastric cancers
such as hereditary diffuse gastric cancers (HDGC)
(Lu). Deletions of exon 8 or 9, being the Ca2+ binding
sites in the intracellular domain, were most common
[21]. In our study, positive staining for E-cadherin was
much more frequent in intestinal-type carcinomas
according to Lauren's classification than in diffuse
type. No statistically significant correlation was also
observed between E-cadherin expression and patients'
gender or histological differentiation grade. This is
consistent with the results reported by Chen et al. [22],
who found no correlation between E-cadherin and can-
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Fig. 1. Correlation of E-cadherin protein expression in main mass
of tumor with survival of patients with advanced gastric cancer.
Fig. 2. Correlation of β-catenin protein expression in main mass of
tumor with survival of patients with advanced gastric cancer.
Fig. 3. Correlation of α-catenin protein expression in main mass of
tumor with survival of patients with advanced gastric cancer.
Fig. 4. Correlation of γ-catenin protein expression in main mass of
tumor with survival of patients with advanced gastric cancer.
cer stage, vascular invasion, lymph node involvement
or the presence of distant metastases.  However, loss of
E-cadherin expression was much more frequent in car-
cinomas that metastasize to distant organs than in
those which do not [22]. On the other hand, Scartozzi
et al. [23] observed "abnormal" E-cadherin expression
more frequently in diffuse-type gastric cancer than in
intestinal type according to Lauren's classification.
Karayiannakis et al. [24] found a significant correla-
tion of "abnormal" E-cadherin  expression with tumor
differentiation grade, location and lymph node
involvement. Loss of normal E-cadherin expression
can serve as a differentiation marker in gastric carci-
noma [24]. Moreover, some authors suggest that the
loss of "normal" E-cadherin expression can be an early
stage in the carcinogenesis of the intestinal-type gas-
tric carcinoma [25]. We observed a relationship
between the loss of E-cadherin expression and lymph
node involvement. Similar results were reported by
Karayiannakis et al. [24], who showed that "abnormal"
E-cadherin expression (loss of membrane expression)
correlated with metastases to lymph nodes. Also Ohno
et al. [26] reported that tumors with "abnormal" E-cad-
herin expression positively correlated with venous
invasion and lymph node metastasis. However, other
researchers described lack of correlation between
"abnormal' E-cadherin expression and lymph node
involvement [27]. No correlation was also found
between E-cadherin expression and the lymphatic
pathway of invasion or lymph node metastasis [28].
The E-cadherin-catenin complex plays a fundamental
role in the development and maintenance of adhesion
between epithelial cells. Changes in any of its compo-
nents may lead to loss of cell adhesion and thus con-
tribute to cancer formation  [26]. Mutation in E-cad-
herin causes "abnormal" nuclear β-catenin location.
We observed positive β-catenin expression most fre-
quently in tumors surpassing the serosa or penetrating
all over the gastric wall as compared to carcinomas
invading the mucous and submucous membrane and
the muscular layer. Similar results were reported by
Utsunomjya et al. [31], who described  β-catenin
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Fig. 5. Cytoplasmic cell staining pattern  of E-cadherin in primary tumor. Fig. 6. Expression of β-catenin in neoplastic cells. 
Fig. 7. Expression of α-catenin protein  in primary tumor. Fig. 8. Expression of γ-catenin in main mass of gastric tumor.
expression as normal or abnormal. Abnormal expres-
sion significantly correlated with diffuse-type adeno-
carcinoma and invasion depth. However, according to
other researchers no correlation can be found between
E-cadherin or β-catenin expression and the invasion
depth [27]. What is more, neither nuclear nor cyto-
plasmatic expression was found in the deep gastric
wall referred to as the invasion front [32]. This is in
agreement with the finding reported by Miyazawa et
al. [33] that the nuclear β-catenin expression becomes
reduced in correlation with depth of invasion. Statisti-
cal analysis showed a significant relationship between
β-catenin expression and lymph node metastasis. This
has been confirmed in literature [27]. The expression
of β-catenin was found to be closely correlated with
lymph node involvement and was substantially higher
when lymph node metastasis were present [34]. On the
other hand, "abnormal" β-catenin expression showed
no correlation with lymph node involvement [31]. We
observed positive reaction for β-catenin mainly in car-
cinomas located in 1/3 of the lower or central part of
the stomach or occupying the whole organ. However,
we found no correlation between β-catenin expression
in the main mass of tumor and its histological differ-
entiation according to Lauren criteria and patients'
gender, which has been confirmed by other authors
[35, 36]. On the other hand, Ohno et al. [26] showed 
a statistically significant correlation between β-catenin
expression and degree of tumor histological differenti-
ation. A reduction in membranous β-catenin expres-
sion was associated with age, gender, tumor size or
lymph node involvement, but not with histological
type, tumor progression or prognosis in gastric carci-
noma [36]. However, the reduction was related to low
tumor differentiation grade [35]. The "abnormal" 
β-catenin expression closely correlated with diffuse-
type gastric adenocarcinoma  [31]. We observed a
strong, statistically significant correlation of γ-catenin
expression in the main mass of tumor with Lauren's
classification and histological differentiation grade.
Positive staining for this protein was more common in
the intestinal type at moderate grade of differentiation
(G2). The other clinicopathological parameters did not
correlate with γ-catenin expression. Moreover, we
found no relationship between any of the parameters
examined and tumor α-catenin expression. This is not
consistent with the findings reported by Joo et al. [37],
who observed reduced expressions of E-cadherin, α-,
β- and γ-catenin much more frequently in diffuse-
rather than intestinal-type early carcinoma according
to Lauren's classification. A reduction in the expres-
sion of the E-cadherin-catenin complex correlated
with low differentiation grade but not with age, gender,
tumor size, location, macroscopic type, depth of inva-
sion or lymph node involvement. This seems to indi-
cate that dysfunction of the E-cadherin-catenin com-
plex in the early stage of carcinogenesis plays a criti-
cal role in damaging tissue architecture and differenti-
ation in early gastric carcinomas [37]. The E-cadherin-
catenin complex may have an important role in the
genesis of histological differentiation and may serve as
a marker of gastric carcinoma differentiation [38]. The
complex plays a key part in the intercellular adhesion
of epithelial cells. Abnormal expression (cytoplasmic)
and function of its respective components are involved
in tumor progression and metastasis. A significant rela-
tionship has been revealed between the expression of
E-cadherin and β-catenin with histological type and
differentiation grade of gastric carcinoma. Moreover, a
correlation has been found between the expression of
γ-catenin and histological type [39]. Abnormal expres-
sion of the E-cadherin-catenin complex may affect
tumor growth type. Song et al. [40] showed a relation-
ship between the complex expression and tumor
growth inhibition in the stomach. The change in the
complex expression from membranous to cytoplasmic
seems to affect the macroscopic pattern of tumor
growth, similarly to Lauren's classification, stage of
advancement or size  [40]. In our study, positive stain-
ing for the E-cadherin-catenin complex proteins was
more frequent in the intestinal type tumors. However,
Shun et al. [41] observed the expression of E-cadherin,
α- and γ-catenin in diffuse type tumors according to
Lauren's classification. Moreover, they found higher
frequency of abnormal E-cadherin expression and
lower frequency of abnormal β-catenin level in
patients with lymph node involvement [41].  In our
study, the survival rate in patients with advanced gas-
tric carcinoma showed a statistically significant corre-
lation with E-cadherin expression in the main mass of
tumor. In E-cadherin positive patients, survival rate
was significantly lower as compared to those without
the expression, which suggests that positive staining
for this protein in tumor is an unfavorable prognostic
factor. We observed similar correlation between 
γ-catenin expression in the main mass of tumor and
survival rate. These data, however, were not statisti-
cally significant. We also demonstrated that the sur-
vival time in patients with tumor α- and β-catenin
expression was much longer as compared to those
without. The results may indicate a prognostically
beneficial role of α- and β-catenin in patients with
advanced gastric carcinomas. The data, however, were
not statistically significant. Ramesh et al. [35]
revealed a relationship between the reduction in β-
catenin expression and low differentiation grade of
gastric cancers and shorter survival, but not between
E-cadherin or α-catenin expression and survival. The
results suggest that reduced membranous β-catenin
expression may implicate unfavorable prognosis in
gastric carcinoma. The expression of β-catenin, like
invasion depth and lymph node involvement, was an
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independent prognostic factor associated with shorter
survival time after surgery [31]. Longer postoperative
survival was noted for carcinomas in which membra-
nous β-catenin expression was maintained irrespective
of carcinoma type, differentiation grade or advance-
ment stage. Patients with unchanged normal membra-
nous staining for E-cadherin and β-catenin were found
to survive 3-5× longer than those with its loss [43].
Thus, the loss of membranous staining for E-cadherin
and β-catenin in patients with gastric carcinoma is
associated with poor prognosis [2, 38]. Liu et al. [44]
observed that the 5- year-survival rate in patients with
lymph node metastases and with adhesion molecule
expression (cad-cat complex) was significantly lower
as compared to those with metastasis and absent com-
plex protein expression. A comparison of the expres-
sion pattern between the main mass of tumor and the
affected lymph node can provide new information for
patients with advanced gastric carcinoma [44]. Sum-
ming up, our findings indicate a relationship between
the expression of the E-cadherin-β-catenin complex
and lymph node involvement in advanced gastric car-
cinomas. Moreover, we observed a correlation
between the expression of α-, β-catenin and such inva-
sion factors as tumor differentiation grade or Lauren's
classification. We also demonstrated that the E-cad-
herin expression can be an unfavorable prognostic fac-
tor for patients with gastric carcinoma. 
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